TABLE 2.
Case no. | Timing of episodes of allograft rejectiona |
Infectious episodes |
||
---|---|---|---|---|
Before diagnosis of EBV (days) | After diagnosis of EBV (days) | Before diagnosis of EBV | After diagnosis of EBV | |
1 | None | +17 | Blood cultured staphylococci and CMV | Candida pharyngitis, CMV pneumonitis, staphylococcal septicemia |
2 | −35, −13 | +18 | None | Escherichia coli (abdominal wound) |
3 | None | +5, +38, +111 | Herpes simplex (lip) | None |
4 | −10 | +133, +169, +307 | CMV viremia | Urine-cultured CMV, E coli, and S fecalis |
5 | None | None | CMV hepatitis, pneumocytis infection | S viridans pharyngitis |
6 | −20 | + 11, +80 | Herpes simplex, Streptococcus viridans pharyngitis | Cholangitis, bile-cultured coagulase negative staphylococci, S fecalis |
7 | −33 | +8 | CMV uveitis | Bile-cultured citrobacter, S fecium, candida |
8 | −2 | +13 | Urine-cultured Candida stellatoidea | Groin wound infection by S fecalis, coagulase-negative staphylococci |
9 | −3, −37 | None | None | None |
10 | None | +25 | None | Urine cultured E coli, enterococci, candida. Bronchoalveolar lavage–cultured candida |
−, number of days rejection preceded the onset of a clinical syndrome; +, number of days that rejection occurred after the diagnosis of viral syndrome.